United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 6 minute read General business news CEA Industries’ $250m buyback: Can a BNB-backed bet really lift shareholder value? CEA Industries (NASDAQ: BNC) unveils $250M buyback to lift BNB-per-share and NAV, signaling confidence and a high-risk growth strategy investors must watch. byPallavi MadhirajuSeptember 22, 2025